Use this version only

Similar documents
Please inform the Diabetes Nurse Specialist that this patient has been admitted within 24hrs of admission.

Diabetic Ketoacidosis (DKA)

Guideline for Children with Type 1 or Type 2 Diabetes on Insulin Requiring Surgery or Sedation

Staff at the Nottingham Children s Hospital. Guidelines process.

Pediatric Diabetic Ketoacidosis (DKA) General Pediatrics Admission Order Set

DAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES

Integrated Care Pathway (ICP) for Children and Young People with Diabetic Keto-acidosis (DKA)

Hyperglycaemic Emergencies GRI EDUCATION

LRI Children s Hospital

Country Health SA Local Health Network. Version control and change history

SCENARIO. Maternal Medicine -DKA LEARNING OBJECTIVES

Objectives. Why is blood glucose important? Hypoglycaemia. Hyperglycaemia. Acute Diabetes Emergencies (DKA,HONK)

Objectives. Why is blood glucose important? Hypoglycaemia. Hyperglycaemia. Acute Diabetes Emergencies (DKA,HONK)

Diabetic Ketoacidosis (DKA) Critical Care Guideline Two Bag System

COMPLIANCE WITH THIS DOCUMENT IS MANDATORY

HHS. Hyperglycaemic Hyperosmolar State Care Pathway 1 Presenta8on to 6 hours. Page 1 of 2 AFFIX PATIENT LABEL ! INFORM DIABETES TEAM OF ADMISSION!

DIABETIC KETOACIDOSIS MANAGEMENT PLAN:

Guidelines for the care of Children with Diabetes Mellitus undergoing Surgery

MANAGEMENT OF PREGNANT WOMEN WITH DIABETES WHO ARE IN-PATIENTS IN THE ROYAL INFIRMARY

Country Health SA Local Health Network

DIABETES MELLITUS. IAP UG Teaching slides

Guidelines for the Management of Diabetic Ketoacidosis (DKA) in Adults Inpatient Diabetes Steering Group

A I Page 1 of 10. SIMPSON CENTRE FOR REPRODUCTIVE HEALTH ROYAL INFIRMARY of EDINBURGH. Clinical Protocol

Lynda Astbury Lead Diabetes Specialist Nurse

Pediatric Intensive Care Unit (PICU) Pediatric Diabetic Ketoacidosis (DKA) Admission Order Set

Diabetes Newly Diagnosed with NO evidence of DKA

With Dr. Sarah Reid and Dr. Sarah Curtis

Diabetic Ketoacidosis

ISOVALERIC ACIDAEMIA -ACUTE DECOMPENSATION (standard version)

Executive Summary Management of Type 1 Diabetes Mellitus during illness in children and young people under 18 years (Sick Day Rules)

Case TWO. Vital Signs: Temperature 36.6degC BP 137/89 HR 110 SpO2 97% on Room Air

Diabetic Ketoacidosis: When Sugar Isn t Sweet!!!

Title Management of Children and Young People with Newly Diagnosed Type 1 Diabetes Mellitus Guideline

PREOPERATIVE ANAEMIA PATHWAY

ADVOCATE CHRIST MEDICAL CENTER DKA (DIABETIC KETOACIDOSIS) TREATMENT GUIDELINES

Suboptimal hydration harms patients.

DIABETIC KETOACIDOSIS

Inpatient Diabetes and Hyperglycaemia. Philip Dyer Heart of England NHS Foundation Trust Birmingham

Peri-Operative Guidelines for Management of Diabetes Patients

THE COLLEGES OF MEDICINE OF SOUTH AFRICA Incorporated Association not for gain Reg No/Nr 1955/000003/08

Pre admission & surgery Pre-admission Nurses Association SIG Catherine Prochilo Credentialled Diabetes Nurse Educator Sat 23 March 2013

INFLECTRA Infliximab Infusion 1,2 & 3

PHYSICIAN SIGNATURE DATE TIME DRUG ALLERGIES WT: KG

Chapter Goal. Learning Objectives 9/12/2012. Chapter 25. Diabetic Emergencies

DIABETIC KETOACIDOSIS (DKA) K E M I A D E Y E R I, P G Y - 1

GESTATIONAL DIABETES (DIET/INSULIN/ METFORMIN) CARE OF WOMEN IN BIRTHING SUITE

PHARMACOLOGY AND PHARMACOKINETICS

GUIDELINES FOR THE TREATMENT OF DIABETIC KETOACIDOSIS (to be used in conjunction with DKA prescription and monitoring chart)

Pathway for Adult Patients with Diabetes attending the Emergency Department (ED) with Hypoglycaemia

PEDIATRIC DIABETIC KETOACIDOSIS

DRUG ALLERGIES WT: KG

George Ford MD MS Assistant Professor Pediatric Endocrinology ETSU and Niswonger Children s Hospital

PREOPERATIVE ANAEMIA PATHWAY

Diabetes Emergency Caesarean section or other unplanned surgery (GL822)

Management of acute asthma in children in emergency department. Moderate asthma

Managing Hyperglycaemia in Acute (Adult) Inpatients Requiring Enteral Feeding Guidelines

TOO SWEET TOO STORMY. CONSULTANTS: Dr. Saji James Dr. J. Dhivyalakshmi Dr. P. N. Vinoth. PRESENTOR: Dr. Abhinaya PG I (M.D Paeds)

TYPE 1 DIABETES MELLITIS CARE OF WOMEN IN BIRTHING SUITE

Nursing Management Pre /Post Thrombolysis in Stroke

FBC, HbA1c, U/E, FT4, Blood Gas, Thyroid antibodies, TSH, Coeliac screen, GAD antibodies, Islet cell antibodies, and insulin antibodies.

Diabetes, Ketone testing in Type 1 Diabetes

Diabetes (DIA) Measures Document

NEONATAL HYPOXIC-ISCHAEMIC ENCEPHALOPATHY (HIE) & COOLING THERAPY

Neonatal Parenteral Nutrition Guideline Dr M Hogan, Maire Cullen ANNP, Una Toland Ward Manager, Sandra Kilpatrick Neonatal Pharmacist

For The Management Of. Diabetic Ketoacidosis

I have no financial disclosures

Individual healthcare plan for Type 1 diabetes. for children/young people with diabetes in schools and Early Years settings

INTRAVENOUS FLUIDS PRINCIPLES

Index No: MMG11/1. Version: 1. Date ratified: 12 th November 2013

INTRAVENOUS FLUID THERAPY

undiagnosed type 1 diabetes in children is a medical emergency. A Healthcare Professionals guide to an early diagnosis

September 2014 V0.17. Paediatric Daily Fluid Prescription & Balance Chart

Printed copies of this document may not be up to date, obtain the most recent version from

East of England Children & Young People s (CYP) Diabetes Network

Acute Stroke - Management of Hyperglycaemia. Contents

DOCUMENT CONTROL PAGE

Diabetes Medical Management Plan

Brief summary of the NICE guidelines December 2013

Clinical Guideline DKA

East of England Paediatric Diabetes Network

East of England Children & Young People s (CYP) Diabetes Network

3 HYDROXY 3 METHYLGLUTARYL CoA (3 HMG CoA) LYASE DEFICIENCY RECOMMENDATIONS ON EMERGENCY MANAGEMENT OF METABOLIC DISEASES

Clinical Guideline for the management of paediatric patients with Diabetes Type 1 & 2 requiring Surgery or General Anaesthetic. V4

ALL orders are active unless: 1. Order is manually lined through to inactivate 2. Orders with check boxes ( ) are unchecked

Diabetic Keto Acidosis

Insulin Tolerance Test Protocol - RNS Endocrinology

Developing a pathway of. and care planning for people with diabetes

Neonatal Hypoglycaemia Guidelines

Chapter 8 ADMINISTRATION OF BLOOD COMPONENTS

SARASOTA MEMORIAL HOSPITAL NURSING PROCEDURE

The Management of Children and Young People with Newly Presenting Diabetes Clinical Guideline V5.0 December 2018

PAEDIATRIC FEBRILE NEUTROPENIA CARE PATHWAY

Peri-operative management of the surgical patient with diabetes GL059

Chapter 16 Nutrition, Fluids and Electrolytes, and Acid-Base Balance Nutrition Nutrients Water o Functions Promotes metabolic processes Transporter

Clinical Guidance. Management of hypoglycaemia in paediatric diabetes

PAEDIATRIC FLUIDS RCH DEHYDRATION

Children & Young People s Directorate Paediatric-Neonatal Guidelines Checklist & Version Control Sheet

Acute Stroke with Alteplase Administration Order Set

Guideline on Sick day rules for children and young people with diabetes on insulin

10. Severe traumatic brain injury also see flow chart Appendix 5

Transcription:

Integrated Care Pathway PAEDIATRIC DIABETIC KETOACIDOSIS (DKA) Use this version only Patient Label Details Ward: Consultant: Named Nurse: Date of Admission: Date of Discharge/Transfer: ALL STAFF TO WRITE IN BLACK INK WITHIN THE PATHWAY. DOCTORS WRITE AGAINST GREEN TEXT, NURSES AGAINST BLACK TEXT Doctors /Diabetes Specialist Nurse Green Nurses: Black Therapists: Red ALL STAFF WRITING IN THIS ICP SHOULD GIVE A SAMPLE SIGNATURE BELOW Name (print) Position Sample Signature Initials Definition Diabetic Ketoacidosis Adapted ISPAD Consensus guidelines for the management of type 1 diabetes mellitus in children and adolescents Glycosuria and ketonuria Hyperglycaemia (Blood glucose (BG) >11 mmol/l) ph <7.3 Bicarbonate <15 mmol/l and who are: 5% or more dehydrated vomiting drowsy NB Children <5% dehydrated and not clinically unwell usually tolerate oral re-hydration and subcutaneous insulin DKA ICP February 2005 Reviewed February 2011 Version 4 1

ALGORITHM FOR THE MANAGEMENT OF DIABETIC KETOACIDOSIS IMMEDIATE ASSESSMENT Clinical history Polyuria Polydipsia Weight loss Abdominal pain Tiredness Vomiting Confusion Clinical signs Assess dehydration Deep sighing respiration (kaussmaul) Lethargy/drowsiness and vomiting Diagnosis confirmed DIABETIC KETOACIDOSIS Contact senior staff Biochemical signs Ketones in urine Elevated blood glucose Acidaemia Shock (reduced peripheral pulses) reduced conscious level Coma, decreased CRT, reduced BP Dehydration 5% Clinically acidotic (hyperventilation) Not in shock Vomiting Clinically well, dehydration <5% Tolerating fluids orally Resuscitation Airway/nasogastric tube Breathing (100% O 2) Circulation 0.9% NaCl 10mL/kg over 10-30 minutes until circulation restored. May be repeated IV Therapy Calculate fluid requirements correct over 48 hours 0. 9% NaCl with KCl 40 mmol/l ECG for elevated T waves Low dose continuous Insulin infusion 0.05 units/kg per hour Continue SC Lantus/Levemir Therapy Start with SC insulin Continue oral hydration No improvement Acidosis not improving Re-evaluation IV fluid calculations Insulin delivery systems and dose Need for additional resuscitation Consider sepsis Critical observations Hourly blood glucose Hourly fluid input / output Neurological status at least hourly Electrolytes at least two hourly after start of IV therapy Monitor ECG for T wave changes Blood glucose 6-14 mmol/l or Blood glucose falls > 5 mmol/l per hour IV therapy Change to 0.9% NaCl + 5% dextrose with KCl 40 mmol/l Discuss with Consultant DO NOT STOP INSULIN Blood glucose 6mmol/L or Blood glucose falls >5mmol//L per hour 0.9% NaCl + 10% dextrose with KCl 40 mmol/l Neurological deterioration Warning signs Headache, slowing heart rate, irritability, decreased conscious level, incontinence, rapid fall in serum sodium > 5mmol/hour Exclude Hypoglycaemia Is it cerebral oedema? Improvement Clinically well, tolerating oral fluids Transition to SC insulin Start SC insulin then Stop IV insulin 30 minutes later Management Give 3 ml/kg of 2.7% NaCl over 30 mins. See Cerebral Oedema guideline on next page

CEREBRAL OEDEMA This is a medical emergency. Once suspected it should be treated immediately. Call for senior help. Background Cerebral oedema is a major cause of mortality and morbidity in children with diabetic ketoacidosis. It can occur any time up to 24 hours after the start of resuscitation. It can be present at the presentation of DKA. One of the most important principles of management is the slow correction of biochemical abnormalities. This will help prevent the development of cerebral oedema. Risk Factors Young age (< 5 years) Adolescents pco2 < 2 kpa at presentation ph < 7.1 at presentation > 40mL/kg IV Fluid in first 4 hours Rapid falls in corrected Sodium (> 5 mmol/l/hour) NaHCO 3 therapy Raised serum urea Hyperventilation post-intubation Headache Impaired level of consciousness Confusion Convulsions Irritability Incontinence Hypertension Bradycardia Low saturations Change in neurological status Focal neurology Abnormal posturing Seizures Symptoms Signs Management Increase frequency of neurological observations to every 15 minutes Exclude hypoglycaemia Give 3 ml/kg of 2.7% NaCl over at least 30 minutes (this is kept on Ash Ward and in A&E) o If there is a response this can be repeated but watch plasma and corrected sodium levels Restrict fluids to 50% maintenance and replace the deficit over 72 hours Nurse at 15 head up and keep head in midline Call anaesthetists as may need intubation and ventilation Liaise with PICU Consider cranial imaging if patient stabilises Careful documentation in notes

USE ADDRESSOGRAPH LABEL IF AVAILABLE NAME: ADDRESS: Age & Sex: Phone No: GP & Surgery: GP phone no: Admitting Consultant: Date of birth: Hospital Number: Source & Type of Referral: Information obtained from: DATE & TIME OF INTERVIEW: PRESENTING COMPLAINT(S): HISTORY OF PRESENTING COMPLAINT(S): Continue on page 6 if necessary PAST MEDICAL HISTORY: PERINATAL HISTORY Delivery Type: Neonatal Problems: DRUG HISTORY/ALLERGIES IMMUNISATIONS: Other Any Problems: DEVELOPMENTAL HISTORY EDUCATION (School / Nursery)

DATE./ /. PHYSICAL EXAMINATION: Weight: kg ( centile) Last Clinic Weight kg Height: cm ( centile) HR BP Temp RR O2 sats Capillary refill time Capillary blood glucose Urinary ketones Glasgow coma score: % Dehydration Time Assessment / Observations Sign Reason for variance & action taken Sign Airway protected Oxygen given 100% via face mask Maintain NBM until assessed Consider NG tube IV access obtained x 2 IV cannulae in situ, and secured position Cardiac monitor (consider T wave changes) Consider urinary catheter Commence ½ hourly recordings of B/P pulse and respiratory rate 1-2 hourly recordings of temperature Hourly fluid balance of input &output Record GCS ¼ hrly for 1 st hour ½ hrly for next hour 1 hrly thereafter DKA ICP February 2005 Reviewed February 2011 Version 4 5

DATE MULTIDISCIPLINARY NOTES FOR ADMISSION SIGN

ADMISSION DAY IMMEDIATE MANAGEMENT DATE././. Time Initial treatment Sign Reason for variance & action taken Sign Calculate fluid requirements Prescribe fluids as per requirements If shock is present 0.9% NaCl 10 ml/kg over 10-30 minutes No more than 2 boluses unless discussed with Consultant FLUID REQUIREMENT = DEFICIT + MAINTENANCE - BOLUSES The calculate of deficit is specific for the management of DKA only. Initial fluid should be with 0.9% NaCl with potassium chloride 40 mmol/l if blood glucose > 14 mmol/l FLUID REQUIREMENT CALCULATION Maintenance 100 ml/kg for first 10 kg ml 50 ml/kg for second 10 kg ml 20 ml/kg for each further kg ml Total for 24 hours (Maximum fluid volume per day: 2000 ml for females and 2500 ml for males) ml Deficit % Dehydrated (Maximum 8%) body weight 10 ml Generally replaced over 48 hours. Replace over 72 hours if concerned about cerebral oedema Total Fluid Calculation Maintenance x 2 ml + Deficit ml - Resuscitation Boluses ml = Total for 48 Hours ml Divide by 48 for hourly rate ml/hour If blood glucose level is > 14 mmol/l then use 0.9% NaCl with 40 mmol/l Potassium Chloride If blood glucose level is between 6-14mmol/L or falling at >5mmol/L per hour, change to 0.9% NaCl + 5% Dextrose with 40 mmol/l Potassium Chloride If blood glucose level is 6mmol/L or continues to fall at > 5 mmol/l per hour, change to 0.9% NaCl + 10% Dextrose with 40mmol/L Potassium Chloride It is useful to write all 3 different bags of fluids up at the start. Clearly document at what glucose levels each bag of fluid is to run at (as above). DKA ICP February 2005 Reviewed February 2011 Version 4 7

ADMISSION DAY IMMEDIATE MANAGEMENT DATE././. Time Initial treatment Sign Reason for variance & action taken Sign Commence IVI soluble insulin 50 units made up to 50 ml with 0.9% NaCl @ 0.05 units/kg/hr Hourly blood glucose analysis 2-4 hourly U&E and blood gas Discuss patient with Consultant If patient on Lantus/Levemir do not stop whilst on IV insulin INSULIN CONTINUOUS LOW DOSE INTRAVENOUS INFUSION OF INSULIN IS THE PREFERRED METHOD Make up a solution of 1 unit per ml of human soluble insulin (e.g Actrapid) 50 units made up to 50mL with 0.9% NaCl in a syringe pump. Flush the giving set with 5 ml of insulin infusion as the insulin may be absorbed into the plastic. The solution should run at 0.05 units/kg/hour (0.05 ml/kg/hour) If the rate of blood glucose fall exceeds 5 mmol/l per hour, or falls to < 14 mmol/l, add dextrose to the IV fluids. Do not alter the insulin dose without consulting senior medical staff. NB: All Insulin should be prescribed on the insulin/glucose monitoring chart. Time Immediate Investigations Sign Reason for variance & action taken Sign Blood glucose analysis Lab blood glucose HbA1c Full blood count Urea and electrolytes Venous blood gas Thyroid function Coeliac screen Islet cell and GAD antibodies (if new diabetic) Consider Urine MC & S Throat swab CXR, Blood culture Other (please specify) Urine test for glucose and ketones DKA ICP February 2005 Reviewed February 2011 Version 4 8

ADMISSION DAY CONTINUED DATE././. Time Communication Sign Reason for variance and action taken Sign Explanations given to patient and family as appropriate Specific communication needs identified. Inform porter of impending patient transfer Inform bleep holder of patient admission bleep 5119 Ensure patient name band and allergy band in situ as appropriate PLAN FOR PATIENT CARE AND INFORMATION GIVEN TO PARENTS: (CONTINUE OPPOSITE PAGE IF NECESSARY) Signature: Dr s Name (printed): Grade: Bleep No: DKA ICP February 2005 Reviewed February 2011 Version 4 9

DATE MULTIDISCIPLINARY NOTES FOR ADMISSION SIGN DKA ICP February 2005 Reviewed February 2011 Version 4 10

DATE MULTIDISCIPLINARY NOTES FOR ADMISSION SIGN DKA ICP February 2005 Reviewed February 2011 Version 4 11

DATE MULTIDISCIPLINARY NOTES FOR ADMISSION SIGN DKA ICP February 2005 Reviewed February 2011 Version 4 12

ADMISSION TO WARD DATE././. Initials required for each shift Clinical assessments E L N Reason for variance and action taken Sign Secure IVI s and check sites Complete hourly fluid balance chart Measure all urine and chart on fluid balance Test all urine for glucose and ketones, document. Monitor and record blood glucose hourly. Inform medical staff if < 6 or > 14 mmol/l or if blood glucose decreasing more than 5mmol/L per hour. Record and chart hourly observations including O2 saturation respiratory rate and neurological observations. Consider cardiac monitor Record waterlow score NB: Consider cerebral oedema if deterioration in neurological observations, heart rate, blood pressure or O 2 saturation s If blood glucose level is between 6-14mmol/L or falling at > 5mmol/L per hour, change to 0.9% NaCl + 5% Dextrose with 40 mmol/l Potassium Chloride If blood glucose level is 6mmol/L or continues to fall at > 5 mmol/l per hour, change to 0.9% NaCl + 10% Dextrose with 40mmol/L Potassium Chloride Initials required for each shift Hygiene E L N Reason for variance and action taken Sign Continue nil by mouth (may have ice chips) Give / assist with regular mouth care including teeth cleaning Regular hygiene Initials required for each shift Communication E L N Reason for variance and action taken Sign Explain treatment to patient and family as appropriate Inform diabetes nurse specialist of patients admission Inform diabetes team of patient admission Inform dietitian of patient admission Introduce and inform play specialist as appropriate Discharge Sign Reason for variance and action taken Sign Consider giving information pack (If new diabetic) DKA ICP February 2005 Reviewed February 2011 Version 4 13

DATE MULTIDISCIPLINARY NOTES FOR ADMISSION TO WARD SIGN DKA ICP February 2005 Reviewed February 2011 Version 4 14

DATE MULTIDISCIPLINARY NOTES FOR ADMISSION TO WARD SIGN DKA ICP February 2005 Reviewed February 2011 Version 4 15

DATE MULTIDISCIPLINARY NOTES FOR ADMISSION TO WARD SIGN DKA ICP February 2005 Reviewed February 2011 Version 4 16

Initials required for each shift DAY TWO DATE././. Clinical assessments E L N Reason for variance and action taken Sign Ensure IVI s secure and check sites Complete hourly fluid balance chart Measure all urine and chart on fluid balance Test all urine for glucose and ketones until negative recordings Record hourly blood glucose whilst patient on IV insulin infusion Change insulin infusion set If started on SC insulin discontinue neurological observations and commence 4hourly observations of TPR Record weight Keep IV insulin running for ½ hour after first subcutaneous injection Record food eaten (Do not restrict food because of high blood glucose levels). If tolerating fluids and hungry, not acidotic, blood chemistry within normal parameters and ketones are reducing (do not expect ketones to have disappeared completely) commence SC insulin regimen When IV insulin discontinued, record blood glucose pre-meal and 2 hours post meal, 22:00 and 02:00 Calculate 0.66u/kg/per day ⅓ to be given as Lantus daily. ⅔ to be given as NovoRapid / Humalog in 3 equal divided doses with meals Hygiene E L N Reason for variance and action taken Sign Give / assist with regular mouth care including teeth cleaning Regular hygiene Communication E L N Reason for variance and action taken Sign Explain treatment to patient and carer as appropriate Choose insulin injection pen Education E L N Reason for variance and action taken Sign Commence education to parent & child Insulin injection Blood glucose reading and recording Urine testing and recording Consultation with Dietitian Discharge E L N Reason for variance and action taken Sign Ensure diabetes information pack given Order TTO s DKA ICP February 2005 Reviewed February 2011 Version 4 17

DATE MULTIDISCIPLINARY NOTES FOR DAY TWO SIGN DKA ICP February 2005 Reviewed February 2011 Version 4 18

DATE MULTIDISCIPLINARY NOTES FOR ADMISSION TO WARD SIGN DKA ICP February 2005 Reviewed February 2011 Version 4 19

DATE MULTIDISCIPLINARY NOTES FOR ADMISSION TO WARD SIGN DKA ICP February 2005 Reviewed February 2011 Version 4 20

DAY THREE Initials required for each shift DATE././. Clinical assessments E L N Reason for variance and action taken Sign Review vital signs Record blood glucose pre-meal and 2 hours post meal, 22:00 and 02:00 Continue urinalysis until negative to ketones Give NovoRapid / Humalog as prescribed immediately before main meals or immediately post meals. Do not restrict food because of high blood glucose levels. Snacks in between meals may be required. (Low sugar, high carbohydrate healthy eating plan) Hygiene E L N Reason for variance and action taken Sign Hygiene needs met by patient / carer Education Sign Reason for variance and action taken Sign Commence education to parent and child as appropriate: Insulin injection Blood glucose reading and recording Urine testing and recording Consultation with Dietitian Communication Sign Reason for variance and action taken Sign Discuss with patient / carer relevant issues / concerns, giving time for parents / carer to ask questions. Discharge Sign Reason for variance and action taken Sign Ensure diabetes information pack given Order TTO s CONSIDER DISCHARGE IF DISCHARGE CRITERIA MET PAGE.29 DKA ICP February 2005 Reviewed February 2011 Version 4 21

DATE MULTIDISCIPLINARY NOTES FOR DAY THREE SIGN DKA ICP February 2005 Reviewed February 2011 Version 4 22

DATE MULTIDISCIPLINARY NOTES FOR ADMISSION TO WARD SIGN DKA ICP February 2005 Reviewed February 2011 Version 4 23

DATE MULTIDISCIPLINARY NOTES FOR ADMISSION TO WARD SIGN DKA ICP February 2005 Reviewed February 2011 Version 4 24

DAY FOUR Initials required for each shift DATE././. Clinical assessments E L N Reason for variance and action taken Sign Patient reviewed by medical staff Record blood glucose pre-meal and 2 hours post meal, 22:00 and 02:00 Continue urinalysis until negative to ketones Give NovoRapid / Humalog as prescribed immediately before main meals or immediately post meals. Do not restrict food because of high blood glucose levels. Snacks in between meals may be required. (Low sugar, high carbohydrate healthy eating plan) Hygiene Sign Reason for variance and action taken Sign Hygiene needs met by patient / carer Education Sign Reason for variance and action taken Sign Continue education to parent and child as appropriate: Insulin injection Blood glucose reading and recording Urine testing and recording Consultation with Dietitian Communication Sign Reason for variance and action taken Sign Continue discussions with patient / carer over relevant issues / concerns, giving time for parents / carer to ask questions. Discharge Sign Reason for variance and action taken Sign CONSIDER DISCHARGE IF DISCHARGE CRITERIA MET PAGE 29 DKA ICP February 2005 Reviewed February 2011 Version 4 25

DATE MULTIDISCIPLINARY NOTES FOR DAY FOUR SIGN DKA ICP February 2005 Reviewed February 2011 Version 4 26

DATE MULTIDISCIPLINARY NOTES FOR ADMISSION TO WARD SIGN DKA ICP February 2005 Reviewed February 2011 Version 4 27

DATE MULTIDISCIPLINARY NOTES FOR ADMISSION TO WARD SIGN DKA ICP February 2005 Reviewed February 2011 Version 4 28

DISCHARGE DATE././. INSULIN REGIMEN ON DISCHARGE Insulin Time Dose Clinical assessments Sign Comments Sign Vital signs within normal parameters Blood glucose recordings stable Blood chemistry within normal limits Patient reviewed by paediatric consultant Patient reviewed by diabetic nurse specialist Patient reviewed by dietitian Discharge plan written Education Sign Comments Sign Diabetes information pack given Appropriate explanation given of condition Explanation given of diabetes management Written information of diet plan Demonstration of insulin pen given to parents/carer and child (if appropriate) Patient /carer and or child has demonstrated injections and blood glucose testing Demonstration of blood glucose technique given to parent / carer and child if appropriate Instruction given as how to document blood glucose Demonstration given as how to test urine for ketones and significance Carer / child verbalises understanding of diabetic care and demonstrates ability to provide care. Appropriate outpatient appointments made Contact numbers provided TTOs given to patient/carer and explanation given Discharge letter given to patient/carer DKA ICP February 2005 Reviewed February 2011 Version 4 29

DATE MULTIDISCIPLINARY NOTES FOR DISCHARGE SIGN DKA ICP February 2005 Reviewed February 2011 Version 4 30

DATE MULTIDISCIPLINARY NOTES FOR ADMISSION TO WARD SIGN DKA ICP February 2005 Reviewed February 2011 Version 4 31

DATE MULTIDISCIPLINARY NOTES FOR ADMISSION TO WARD SIGN DKA ICP February 2005 Reviewed February 2011 Version 4 32

Results Flow Sheet Date Time ph pco 2 HCO 3 - BE Glucose Lab Na Actual Na See Below * K Urea Creat CRP TSH ft 4 Hb Plt WBC N L Blood Cultures Urine Culture * Actual Na = (Lab Na+ (Blood Glucose 5) 3 DKA ICP February 2005 Reviewed Febriary 2011 Version 4 33

References & Bibliography Isle of Wight Healthcare NHS Trust (March 2002) Paediatric Ketoacidosis ICP Version 3 Chelsea & Westminster Healthcare NHS Trust Integrated Care Pathway Paediatric Diabetes Dunger,D. et al.(1999) Ketoacidosis; Practical Algorithms in Paediatric Endocrinology Department of Health (April 2003) Getting the right start: National Service Framework for Children Standard for Hospital Services International Society of Paediatric and Adolescent Diabetes (2000)ISPAD Concensus Guidelines for the management of type 1 Diabetes Mellitus in Children and Adolescents http://www.ispad.org/ BSPED Recommended DKA Guidelines. November 2009 DKA ICP February 2005 Reviewed Febriary 2011 Version 4 34